A. Revelli
Professor
S. Anna Hospital, University of Torino, Via Ventimiglia 3, 10126
Professional interests: Reproductive Medicine, Infertility, Assisted Reproduction Techniques, In Vitro Fertilization, Reproductive Endocrinology, Fertility Preservation
Scopus Profile: link
ID ORCID: 0000-0002-5797-3722
Latest articles in Scopus:
Influence of COVID-19 pandemic on the psychological status of infertile couples
Esposito, V., Rania, E., Lico, D., ...Di Carlo, C., Venturella, R.
European Journal of Obstetrics and Gynecology and Reproductive Biology, 2020, 253, 148–153
Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles: a pilot study
Carosso, A., Revelli, A., Gennarelli, G., ...Cavallo, R., Benedetto, C.
Journal of Assisted Reproduction and Genetics, 2020, 37(9), 2315–2326
Human recombinant FSH and its biosimilars: Clinical efficacy, safety, and cost-effectiveness in controlled ovarian stimulation for in vitro fertilization
Bergandi, L., Canosa, S., Carosso, A.R., ...Benedetto, C., Revelli, A.
Pharmaceuticals, 2020, 13(7), 1–23, 136
Is guided, targeted information about the risks of twin pregnancy able to increase the acceptance of single embryo transfer among IVF couples? A prospective study
Masciovecchio, M., Scarafia, C., Razzano, A., ...Benedetto, C., Revelli, A.
Journal of Assisted Reproduction and Genetics, 2020, 37(7), 1669–1674
Morphokinetic analysis of cleavage stage embryos and assessment of specific gene expression in cumulus cells independently predict human embryo development to expanded blastocyst: a preliminary study
Canosa, S., Bergandi, L., Macrì, C., ...Benedetto, C., Revelli, A.
Journal of Assisted Reproduction and Genetics, 2020, 37(6), 1409–1420
Human ovarian cortex biobanking: A fascinating resource for fertility preservation in cancer
Silvestris, E., De Palma, G., Canosa, S., ...Revelli, A., Paradiso, A.V.
International Journal of Molecular Sciences, 2020, 21(9), 3245
A prospective randomized trial comparing corifollitropin-α late-start (day 4) versus standard administration (day 2) in expected poor, normal, and high responders undergoing controlled ovarian stimulation for IVF
Revelli, A., Gennarelli, G., Sestero, M., ...Filippini, C., Benedetto, C.
Journal of Assisted Reproduction and Genetics, 2020, 37(5), 1163–1170